Stay updated with breaking news from Formp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report) was the recipient of a significant drop in short interest in July. As of July 15th, there was short interest totalling 677,000 shares, a drop of 15.1% from the June 30th total of 797,800 shares. Based on an average trading volume of 869,200 shares, the days-to-cover ratio […]
Landscape Capital Management L.L.C. acquired a new position in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 26,220 shares of the biotechnology company’s stock, valued at approximately $315,000. Landscape Capital Management L.L.C. owned […]
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $4.88 and traded as low as $2.81. Oramed Pharmaceuticals shares last traded at $3.03, with a volume of 740,289 shares trading hands. Wall Street Analyst Weigh In ORMP […]
StockNews.com upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday morning. Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group cut shares of Oramed Pharmaceuticals from a buy rating to a hold rating and cut their […]
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) saw a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 789,300 shares, a decline of 19.9% from the March 15th total of 985,700 shares. Based on an average trading volume of 1,690,000 shares, the days-to-cover ratio is […]